H
HemoShear Therapeutics
0 followers
HemoShear Therapeutics develops new treatments for patients with rare metabolic disorders.
Org chart
Brian Wamhoff
Interim CEO
Collapse
Patrick Horn
CMO
Mark Hayes
Acting Chief Regulatory Officer
Mavis Waller
VP, Clinical Operations
Jeffrey Qureshi
VP, Legal Affairs
Mike Simmers
VP, Operations
Paul Sartori
AVP, Organizational Development & Human Resources
Emile J. Velthuisen
Head of Discovery
M. Sol Collado
Executive Director, Head Of Discovery Biology
Ryan Feaver
Executive Director, Head Of Exploratory Biology
Jeanne Joslyn
Accounting/hr Coordinator
Board & advisors
Robert J. Gould
Chairman
John L. Brooks III
Board Member
John Tilton
Board Member
H. Thomas Watkins III
Board Member
Kathleen M. Metters
Board Member
Gerald Cox
Advisor
Moeen Al-Sayed
Advisor
John E. Reardon
Advisor
Arun Sanyal
Advisor
Kimberly Chapman
Advisor
Gregory Enns
Advisor
Jerry Vockley
Advisor
Nicola Longo
Advisor
Mattias Baumgartner
Advisor